Cambridge Heart (NSDQ:CAMH) remained in the red in its 3rd quarter after the company restructured its operations in July, but narrowed its losses by 16.6%.
CareFusion (NYSE:CFN) shares are down slightly today after the medical device company said it would be late in filing its annual report with the SEC, which triggered a delisting warning from the New York Stock Exchange.
CareFusion said it’s negotiating with the securities regulator over how to account for leases of its Pyxis medicine dispensing devices.
The 3 months ended March 31 made up Abiomed’s "best quarter and year in company history, in terms of number of patients supported, revenue growth, and profitability," chairman, president & CEO Michael Minogue said in prepared remarks.
Private equity players are in for some stiff competition this year, as large-cap PE shops invade the middle-market space, according to a report from PE stalwart Bain & Co.
The company’s Global PE Report details a huge “exit overhang” – more aptly deemed an “exit hangover” by PE Hub’s Jonathan Marino – as PE-backed companies seek exits.
And the mega-deals of the past 10 years or so are a thing of the past, according the report, as detailed by Marino.
Carticept Medical closed a $10 million financing led by existing investors Domain Associates, New Enterprise Associates and SonoSite Inc.
The Alpharetta, Ga.-based company said it will use the proceeds to fund the commercial launch of its Navigator computer-controlled drug delivery system. The device uses ultrasound guidance to deliver medications for joint pain.